Fundz

I Bio reported raising $26 Million in an initial SEC Form D filing, from an offering of $26 Million

PUBLIC · IBIOJan 22, 2026

Amount Raised

$26 Million

$26 Million sold, per SEC Form D (first sale Jan 8, 2026)

Round Type

Venture

New YorkManufacturingBiotechnology

Investors

Frazier Life Sciences

Quick answer

iBio raised $26 Million in a funding round, dated January 8, 2026. Investors: Frazier Life Sciences. iBio is based in New York, New York, United States.

How much did iBio raise?
iBio raised $26 Million in a funding round on January 8, 2026.
Who invested in iBio?
Frazier Life Sciences is named as investors in this round.
What does iBio do?
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases.
Where is iBio based and how big is it?
iBio is based in New York, New York, United States. Fundz records about 16 employees.
Who are the decision-makers at iBio?
Fundz holds 2 contacts at iBio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as iBio that raised within 45 days of this round, from Fundz verified event records.

  • Mecademic raised $17M (Funding Round) on February 18, 2026.
  • Intrinsic Foundries raised $1.3M (Seed) on February 17, 2026.
  • Botanix Pharmaceuticals raised $33M (Funding Round) on February 17, 2026.
  • Flyte Aviation, Inc. raised $37M (Funding Round) on February 12, 2026.
  • Ukhi raised $1.2M (Seed) on February 12, 2026.
  • Articulus Surgical raised an undisclosed amount on February 11, 2026.

Who to call at iBio, and when

A new round usually means iBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day iBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at iBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at iBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

iBio

Location

New York, New York, United States

About

iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment iBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for iBio's next move

See what Strategic adds

iBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.